© 2003 by Oxford University Press
© 2003 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Robert G. Roeder, Ph.D., received the Albert Lasker Award for Basic Medical Research from the Albert and Mary Lasker Foundation. The award recognizes Roeder for his research on how human genes are switched on and off. Roeder is head of the Laboratory of Molecular Biology and Biochemistry at Rockefeller University in New York.
V. Craig Jordan, Ph.D., D.Sc., received the 2003 North American Menopause Society/Eli Lilly and Company SERM Research Award. The award recognizes Jordan’s research on raloxifene. Jordan is director of the Lynn Sage Breast Cancer Research Program at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University’s School of Medicine in Chicago.
Jeremy M. Berg, Ph.D., was named director of the National Institute of General Medical Sciences at the National Institutes of Health. Berg is director of the Institute for Basic Biomedical Sciences and professor and director of the Department of Biophysics and Biophysical Chemistry at the Johns Hopkins University School of Medicine in Baltimore. Berg will begin his appointment in November.
John Y. Killen, Jr., M.D., was appointed director of the Office of International Health Research of the National Center for Complementary and Alternative Medicine. He was previously head of the Office of Biodefense Research at the National Institute of Allergy and Infectious Diseases. He started the new position in September.
Craig T. Jordan, Ph.D., has been named director of the Hematologic Malignancies Translational Research Program at the James P. Wilmot Cancer Center at the University of Rochester Medical Center in New York. Jordan was previously at the University of Kentucky’s Markey Cancer Center in Lexington.
Roswell Park Cancer Institute has appointed four new faculty members. Adam R. Karpf, Ph.D., has been appointed assistant member in the Department of Pharmacology and Therapeutics, and Dominic J. Smiraglia, Ph.D., has been appointed assistant member in the Department of Cancer Genetics. Karpf was previously at the Huntsman Cancer Institute, Salt Lake City, and Smiraglia was previously at Ohio State University.
In addition, Victor A. Filadora II, M.D., and Li Li, M.D., have been appointed to the Department of Anesthesiology and Critical Care Medicine. Filadora was previously at Brigham and Women’s Hospital in Boston, and Li was previously at the University of Buffalo School of Medicine and Biomedical Sciences.
David H. Sachs, M.D., has been appointed to Aphton Corp.’s Board of Directors. Sachs is director of the Transplantation Biology Research Center at Massachusetts General Hospital and professor of surgery at Harvard Medical School, both in Boston. Aphton Corp. is a biopharmaceutical company that develops immunotherapy products.
The National Center for Complementary and Alternative Medicine is accepting applications for its first Director’s Fellowship in Complementary and Alternative Medicine Research. The fellowship will prepare an investigator for a career as an independent CAM investigator. The deadline for receipt of applications is Nov. 24, 2003. For more information, e-mail baronch{at}mail.nih.gov.
The American Brain Tumor Association is accepting applications for their Basic Research Fellowships and Translational Research Grants. More information is available at http://www.abta.org/abtaresearchfunding.htm. The deadline for submission is Jan. 7, 2004.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||